
DermTech DMTK
Quarterly report 2024-Q1
added 06-13-2026
DermTech Cash Conversion Cycle 2011-2026 | DMTK
Annual Cash Conversion Cycle DermTech
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.7 | 60.5 | 15.3 | -25.9 | -32.2 | 26.3 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 66.7 | -32.2 | 18.5 |
Quarterly Cash Conversion Cycle DermTech
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 69 | 74.2 | 94 | - | 141 | 115 | 67.3 | - | 17.3 | -9.59 | -26.6 | - | 15.8 | 67.2 | -52.1 | - | -74.5 | -108 | -34.3 | - | 24.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 141 | -108 | 23.8 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 201.91 | -0.57 % | $ 22.4 B | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-2.46 K | $ 3.9 | -9.09 % | $ 5.19 M | ||
|
Castle Biosciences
CSTL
|
31.6 | $ 20.48 | -1.06 % | $ 594 M | ||
|
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
2.11 | - | -61.36 % | $ 2.46 M | ||
|
Fulgent Genetics
FLGT
|
51.8 | $ 18.53 | -0.8 % | $ 570 M | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
79.6 | $ 128.84 | -2.11 % | $ 16.2 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 22.91 | -0.26 % | $ 1.22 B | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
Interpace Biosciences
IDXG
|
62.9 | $ 1.65 | 3.12 % | $ 7.3 M | ||
|
ICON Public Limited Company
ICLR
|
52.5 | $ 146.88 | 0.48 % | $ 11.5 B | ||
|
Illumina
ILMN
|
147 | $ 163.68 | 1.68 % | $ 25.4 B | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
97.3 | $ 103.39 | -1.08 % | $ 6.98 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 190.49 | 1.59 % | $ 9.44 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 470.34 | 0.64 % | $ 13.6 B | ||
|
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 148.0 | 1.46 % | $ 23.7 B | ||
|
Myriad Genetics
MYGN
|
49.3 | $ 4.23 | -2.31 % | $ 392 M | ||
|
NeoGenomics
NEO
|
82.4 | $ 11.03 | -1.12 % | $ 1.41 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 18.5 | -1.57 % | $ 414 M | ||
|
Natera
NTRA
|
48.3 | $ 213.73 | 0.78 % | $ 29.2 B | ||
|
Pacific Biosciences of California
PACB
|
185 | $ 1.35 | 3.05 % | $ 405 M | ||
|
Personalis
PSNL
|
-1.89 | $ 9.78 | 1.98 % | $ 873 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 26.75 | 1.1 % | $ 25.4 B | ||
|
Senseonics Holdings
SENS
|
36.1 | $ 7.26 | 1.04 % | $ 303 M | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
-398 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
172 | $ 2.03 | -1.22 % | $ 4.66 M | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 265.4 | -0.29 % | $ 22.1 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 471.72 | 0.61 % | $ 178 B | ||
|
Trinity Biotech plc
TRIB
|
136 | $ 0.65 | -0.26 % | $ 233 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
83.6 | $ 78.53 | 3.09 % | $ 4.7 B | ||
|
Neogen Corporation
NEOG
|
150 | $ 9.19 | 0.99 % | $ 1.99 B | ||
|
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M |